Maine Ebola Quarantine Underscores Importance of Due Process during Public Health Emergencies
Although the fervor of domestic news coverage regarding the West Africa Ebola outbreaks has subsided, cases that were treated in the U.S. shed light on a public health infrastructure to which Americans rarely give much thought. Among the discussions of travel bans and increased surveillance, an issue arose of particular […]
Rising Pharmaceutical Costs Hit the Generic Market
In 1984, the 98th Congress passed the Drug Competition and Patent Term Restoration Act, better known as the Hatch-Waxman Amendment, creating a statutory scheme wherein generic drug manufacturers will be able to put their products into the market using the pioneer (or branded) drug’s scientific safety and efficacy data. In […]
Virginia’s Controversial Certificate of Public Need (COPN) Law Withstands Legal Challenge
If you are a healthcare provider who wants to establish a new healthcare facility in a state like Virginia, you must first convince the state and your existing business competitors in the state that your healthcare facility is necessary. This is called obtaining a Certificate of Public Need (COPN), also […]
Iodine Tablets as Protection Against Thyroid Cancer – Good Idea or Not?
From October 27, 2014 to December 5, Switzerland is distributing iodine tablets to more than half the country’s population for use in the event of a nuclear disaster. (Bloomberg). People living with a 31-mile radius of a nuclear power plant will receive packages of 12 pills that will keep for […]
Expanded Health Law Provisions Are Influencing the Rate of Premature Births
Preterm birth is the leading cause of death in newborns. In 2013, there were more than 450,000 premature births, which are live births at less than 37 full weeks. An annual March of Dimes report card released this November, indicating that the percentage of premature births decreased to 11.4 percent […]
